DJIA 17,210.94 -176.27 -1.01%
NASDAQ 4,642.71 -38.78 -0.83%
S&P 500 2,003.46 -26.09 -1.29%
market minute promo

MannKind Corp (NASDAQ: MNKD)

6.24 -0.12 (-1.81%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MNKD $6.24 -1.81%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.52
Previous Close $6.36
Daily Range $6.19 - $6.68
52-Week Range $3.80 - $11.48
Market Cap $2.5B
P/E Ratio -10.96
Dividend (Yield) $0.00 (0.0%)
Volume 6,847,685
Average Daily Volume 4,262,356
Current FY EPS -$0.51





MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website:

News & Commentary

No More Needle Pricks? Potentially Game-Changing News for People With Diabetes

Finger pricks are a common method used by diabetics to check their blood sugar levels. But what if that was about to be a thing of the past?

Another Reason MannKind Could Be Up (In 1 Tweet)

Why MannKind Shares Are Up Nearly 5%

MannKind Corporation on Track for Afrezza Launch

MannKind partner Sanofi is close to launching its inhaled insulin Afrezza, but will doctors prescribe it?

The Real News About Afrezza From The JPMorgan Conference

In Case You Missed it, Diabetics May Have a New Worry From an Unlikely Source

A new research study suggests that diabetes patients may have more to worry about than just their disease.

Seeking Alpha's Biotech Weekly: Roche Takes Control, Shire's A Buyer, And More

10 Biotech Stories You Might've Missed This Week

Less Mann in MannKind Corporation

Alfred Mann retires as CEO, but investors needn't worry.

Watch MannKind Closely, A Short Squeeze Could Be Nearing

See More MNKD News...

MNKD's Top Competitors

MNKD $6.24 (-1.81%)
Current stock: MNKD
AMGN $154.85 (-2.54%)
Current stock: AMGN
GILD $102.52 (-2.39%)
Current stock: GILD
BIIB $351.44 (-1.80%)
Current stock: BIIB